ArticleCPT: pharmacometrics & systems pharmacology2023

Copanlisib population pharmacokinetics from phase I-III studies and exposure-response relationships in combination with rituximab.

Peter N Morcos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.